Generic semaglutide is now in India, from about ₹1,500 a month. See if it suits you
lean life.
हिंदी WhatsApp us Talk to an advisor
☰

Could GLP-1 treatment suit me?

Answer three quick questions to see whether weight-loss medicines like Mounjaro or semaglutide might suit you, based on the licensed criteria and Indian BMI guidance.

Medically reviewed and approved by Dr Reina Punj, MBBS, PG Diploma in Endocrinology (University of South Wales, UK), Lead Physician, Lean Life. Approved on 16 November 2026.

Step 1: your height and weight

Your BMI: 31.2

Step 2: do you have any of these?

Step 3: do any of these apply?

You may meet the criteria for GLP-1 treatment

GLP-1 medicines are licensed for adults with a BMI of 30 or more, or 27 or more with a weight-related condition. A doctor will check your history and blood tests before deciding.

Your answers stay on your device; nothing is sent to us. A guide only, not a diagnosis: a doctor makes the final decision.

Who GLP-1 medicines are licensed for

Tirzepatide (Mounjaro) and semaglutide for weight management (Wegovy, Poviztra and approved generics) are licensed for adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition, such as prediabetes, type 2 diabetes, high blood pressure, high cholesterol or sleep apnoea. They're used alongside diet and activity, not instead of them.

Why Indian bodies are different

Indians tend to carry more fat around the abdomen and develop diabetes, fatty liver and heart disease at lower weights than Europeans. That's why Indian guidelines use lower BMI cut-offs: 23 for overweight and 25 for obesity. Your doctor takes this into account. Check your BMI by Indian cut-offs.

Who shouldn't take them

  • Anyone pregnant, trying to conceive or breastfeeding.
  • Anyone with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2).
  • Anyone with a serious allergy to the medicine.

People with past pancreatitis, gallbladder disease, type 1 diabetes, diabetic eye disease or an eating disorder need a careful assessment, and the medicine may not be right for them.

What happens next

A doctor reviews your history, current medicines and blood tests before deciding. See which blood tests are usually done before starting, or book a free advisor call to talk it through.

Questions

Who is eligible for Mounjaro or Wegovy in India?

Adults with a BMI of 30 or more, or 27 or more with a weight-related condition, after a doctor's assessment.

Can I get GLP-1 medicines if my BMI is below 27?

They aren't licensed for that, but because Indians develop weight-related conditions at lower weights, a doctor may discuss your options. Diet and activity usually come first.

Does this checker replace a doctor?

No. It's a guide to help you decide whether to talk to a doctor, who makes the final decision.

References

  1. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022
  2. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021
  3. Misra A et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians. J Assoc Physicians India 2009
  4. Mounjaro summary of product characteristics, European Medicines Agency
  5. Wegovy summary of product characteristics, European Medicines Agency

Want a doctor's view? Start with a free call.

Free advisor call, Monday to Saturday, 10 am to 6 pm, in English or Hindi.

See if I'm eligibleTalk to an advisor